IBDEI110 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16497,0)
 ;;=C81.90^^88^879^90
 ;;^UTILITY(U,$J,358.3,16497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16497,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,16497,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,16497,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,16498,0)
 ;;=D89.2^^88^879^91
 ;;^UTILITY(U,$J,358.3,16498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16498,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,16498,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,16498,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,16499,0)
 ;;=D05.12^^88^879^94
 ;;^UTILITY(U,$J,358.3,16499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16499,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,16499,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,16499,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,16500,0)
 ;;=D05.11^^88^879^95
 ;;^UTILITY(U,$J,358.3,16500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16500,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,16500,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,16500,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,16501,0)
 ;;=D05.10^^88^879^96
 ;;^UTILITY(U,$J,358.3,16501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16501,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,16501,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,16501,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,16502,0)
 ;;=D50.0^^88^879^97
 ;;^UTILITY(U,$J,358.3,16502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16502,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,16502,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,16502,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,16503,0)
 ;;=D50.9^^88^879^98
 ;;^UTILITY(U,$J,358.3,16503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16503,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16503,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,16503,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,16504,0)
 ;;=C46.9^^88^879^99
 ;;^UTILITY(U,$J,358.3,16504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16504,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,16504,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,16504,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,16505,0)
 ;;=C22.0^^88^879^100
 ;;^UTILITY(U,$J,358.3,16505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16505,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,16505,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,16505,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,16506,0)
 ;;=D05.02^^88^879^101
 ;;^UTILITY(U,$J,358.3,16506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16506,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,16506,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,16506,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,16507,0)
 ;;=D05.01^^88^879^102
 ;;^UTILITY(U,$J,358.3,16507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16507,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,16507,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,16507,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,16508,0)
 ;;=D05.00^^88^879^103
 ;;^UTILITY(U,$J,358.3,16508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16508,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,16508,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,16508,2)
 ;;=^5001926
 ;;^UTILITY(U,$J,358.3,16509,0)
 ;;=R59.0^^88^879^62
